Navigation Links
Important funding for nanomedicine research to improve diagnosis and treatment
Date:3/16/2011

This release is available in French.

Toronto (March 16, 2011) Seven new research projects on regenerative medicine and nanomedicine received $16 million in funding. The studies, co-funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Space Agency (CSA), were announced today at the University of Toronto by Dr. Colin Carrie, Member of Parliament for Oshawa; Dr. Jane Aubin, Scientific Director of the Canadian Institutes of Health Research Institute of Musculoskeletal Health and Arthritis; Mr. Gilles Leclerc, Director General, Space Exploration at the Canadian Space Agency; and Professor Peter Lewis, Associate Vice President (Research) at the University of Toronto. "The Government of Canada is proud to support regenerative medicine and nanomedicine projects that will translate into improved health for Canadians," said Dr. Carrie. "The knowledge that emerges from these research projects could also have wide ranging social and economic benefits."

"CIHR is delighted to partner with the Canadian Space Agency to support research aimed at developing technologies and approaches to improve patient outcome," said Dr. Aubin. "The research projects announced today seek to offer new therapies and approaches to treat illnesses and diseases, and ultimately offer better quality of life for patients and their families."

Research on nanomedicine and regenerative medicine is designed to prevent disease and improve human health. Nanomedicine delivers medical technologies that detect or function at the molecular level to diagnose and treat disease, while regenerative medicine stimulates the renewal of bodily tissues and organs or restores function through natural and bioengineered means. Various innovations in these areas have helped combat vascular diseases, cancer, diabetes, multiple sclerosis and other chronic diseases. By promoting research in these areas, CIHR and CSA will be moving Canada to the forefront of modern medical research.

"By working together, CIHR and the CSA are supporting scientific research and innovations that have applications for health care on earth and in space and provide real benefits for Canadians," said Mr. Leclerc. "Our hope is that cutting-edge diagnostic tools will improve astronaut health in space and be adapted for the early detection and treatment of disease here on earth."

"We congratulate the talented researchers who are leading the projects and believe their work on integrating new technologies into health research holds the potential to dramatically change the way we diagnose and treat diseases," said Professor Lewis.

The projects underwent a rigorous and competitive peer review process and were selected according to international standards of scientific excellence.

This funding will enable researchers to potentially:

  • Identify microlesions in multiple sclerosis, using a new tool for quantifying the cause of the disease and how well a treatment is working, Dr. Daniel Ct, Universit Laval;
  • Create personalized nanomedicines that silence cancer-causing genes, Dr. Petier Cullis, University of British Columbia;
  • Develop microchip-based devices to analyze prostate cancer markers in blood, Dr. Shana Kelley, University of Toronto;
  • Generate transplantable, insulin-producing cells from stem cells for diabetes, Dr. Timothy Kieffer, University of British Columbia;
  • Develop innovative sensorimotor rehabilitation approaches for patients with spinal cord injuries or stroke, Dr. Serge Rossignol, Universit de Montral;
  • Study how novel therapeutic interventions can regenerate blood vessels, Dr. Michael Sefton, University of Toronto; and,
  • Develop nanotechnology-enabled image-guided methods of diagnosing and treating lung cancer and vascular diseases, Dr. Gang Zheng, University Health Network.


'/>"/>

Contact: Media Relations
mediarelations@cihr-irsc.gc.ca
Canadian Institutes of Health Research
Source:Eurekalert

Related medicine news :

1. Parents important for keeping adolescents off alcohol
2. Neuroscientists find overlooked brain area is an important locus of depression
3. Researchers find reduced levels of an important neurotransmitter in MS
4. Coma and general anesthesia demonstrate important similarities
5. Researchers discover important link between adrenal gland hormone and brain in hypertension
6. Increased attention to womens health research has yielded gains on some important conditions, but progress lags on others
7. Workers rate safety most important workplace issue in new Labor Day study
8. Street outreach workers an important tool for violence prevention and intervention
9. SIRT1 gene important for memory
10. Healthy Serotonin Levels Shown to Positively Affect many Important Functions of the Mind and Body.
11. Free Clinics Play Important Role for Uninsured in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital Tampa Wound ... Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies the ... hospitals and facilities have earned this distinction. This is the second time the ...
(Date:12/8/2016)... Pennsylvania (PRWEB) , ... December 08, 2016 , ... ... Duck Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which ... , “This was our first franchise-wide Quack Gives Back initiative, ...
(Date:12/8/2016)... and JENNERSVILLE, Pa. (PRWEB) , ... December 08, ... ... that Penn Medicine Southern Chester County, a Property owned by an affiliate of ... million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care center (ACC) ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s ... groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced ... J. Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the ... series, and attorneys from the firm’s global Life Sciences & Medical Technology Group have ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... MOUNTAIN VIEW, Calif. , Dec. 8, 2016 ... it intends to offer newly issued shares of common stock, ... "Shares") pursuant to an underwritten public offering.  The final terms ... at the time of pricing, and there can be no ... completed. IRIDEX expects to use the net proceeds ...
(Date:12/8/2016)... -- Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices Market Outlook to 2022", provides ... Devices market. The report provides value, in millions ... prices (USD) within market segement - Glaucoma Drainage ... and distribution shares data for each of these ...
(Date:12/8/2016)...  The global biosurgery market is expected to grow ... of 2016 to 2021. The market is poised to ... billion in 2016. The market is primarily driven by ... injuries and spinal problems, increasing clearance of biosurgery products ... loss management. In this report, the biosurgery ...
Breaking Medicine Technology: